Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a Single Transrectal Ultrasound(TRUS)-Guided Intraprostatic Injection of NX-1207 in Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Phase III European Study

NCT02003742 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.

NCT NCT02003742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02003742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a Single Transrectal Ultrasound(TRUS)-Guided Intraprostatic Injection of NX-1207 in Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Phase III European Study
Lead sponsor
RECORDATI GROUP
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2013
Completion date
January 29, 2015
Enrollment
104 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary tract symptoms